ARTICLE | Clinical News
Crenolanib regulatory update
November 18, 2016 9:19 PM UTC
Arog said FDA granted Fast Track designation to crenolanib besylate to treat unresectable or metastatic gastrointestinal tumors (GIST) harboring the platelet-derived growth factor receptor alpha (PDGF...